New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 2, 2014
16:18 EDTACRXAcelRx Chief Commercial Officer David Chung resigns
AcelRx Pharmaceuticals announced that David Chung has resigned as Chief Commercial Officer in order to assume the role of CEO of a medical device company. Richard King, the company's President and CEO, will assume the duties and responsibilities of the Chief Commercial Officer, and will lead the continued build-out of the commercial organization and launch preparation for Zalviso until a suitable replacement is found. The Company has begun a search for Mr. Chung's replacement.
News For ACRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 8, 2015
07:02 EDTACRXAcelRx provides update on Zalviso
AcelRx provided a regulatory update on Zalviso intended for the management of moderate-to-severe acute pain in adult patients in the hospital setting. The company has received formal minutes of the telephonic meeting held in early September 2015, with the Division of Anesthesia, Analgesia, and Addiction Products of the FDA. As reflected in the minutes, the Division restated at the meeting a request for clinical data to complement other data AcelRx has developed to assess the overall performance of the Zalviso device. The company is planning to submit a protocol to the Division for a clinical study in post-operative patients designed to evaluate the effectiveness of changes made to enhance product performance. AcelRx expects to be ready to initiate the study in the first quarter of 2016, and likely will await comments on the protocol from the Division. The company will be prepared to work with the FDA to facilitate the timely study initiation.
October 6, 2015
07:01 EDTACRXAcelRx announces initiation of clinical study of ARX-04 in ER patients
Subscribe for More Information
October 5, 2015
09:08 EDTACRXAcelRx price target raised to $10.50 from $8.50 at Roth Capital
Subscribe for More Information
October 1, 2015
06:09 EDTACRXAcelRx to host analyst and investor day
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use